Statement re Change of Trading Address
April 12 2021 - 2:00AM
Statement re Change of Trading Address
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Change of Trading Address
DXS International plc ("DXSP" or the "Company"), the AQSE quoted
clinical decision support developer and supplier of clinical
decision support systems, is pleased to announce that with effect
from 12 April 2021, it is moving to new premises at Tanshire Park,
an established office park in Elstead, Surrey, a short distance
from the current Headquarters.
The move, which has no material financial implications for the
company, to modern and attractive premises offers more flexible
space with an improved work environment from a Covid Secure
perspective. The new premises also have better electronic
connectivity than was previously possible in its old Grade II
listed premises in Wrecclesham near Farnham.
David Immelman said “We are pleased to move to these new
premises which will give our staff and customers an improved
quality of work environment and better reflects our position as a
technical digital enabler providing the latest diagnostic support
systems”.
.
Contacts:
David
Immelman (Chief
Executive)DXS International plc |
01252 719800david@dxs-systems.com |
https://www.dxs-systems.co.uk |
|
Corporate
Advisor |
|
City &
Merchant David Papworth |
020 7101 7676 |
Corporate
Broker |
|
Hybridan
LLPClaire Louise Noyce |
020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment
guidelines and recommendations, from Clinical Commissioning Groups
and other trusted NHS sources, to doctors, nurses and pharmacists
in their workflow and during the patient consultation. This
effective clinical decision support ultimately translates to
improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its
projected efficiency savings.
DXS (AQSE:DXSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
DXS (AQSE:DXSP)
Historical Stock Chart
From Jul 2023 to Jul 2024